JMDC Inc.
Stock Price Chart
2026/03/03 UpdatedPrice Trend
2026/03/03 UpdatedPrice & Trading Details
2026/03/03 UpdatedPRICE
TRADING
Analyst Recommendations 13 analysts
Updated 2026/03/01Shareholder Composition
Updated 2026/03/01Dividend History 3Years Growth
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥16 | +14.3% |
| 2024 | ¥14 | +16.7% |
| 2023 | ¥12 | +20.0% |
| 2022 | ¥10 | - |
Financial Performance
2026/03/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥21,814M | ¥27,809M | ¥30,572M | ¥41,722M |
| Gross Profit | ¥12,589M | ¥15,859M | ¥18,171M | ¥23,849M |
| Operating Income | ¥4,784M | ¥5,927M | ¥5,485M | ¥8,718M |
| Pretax Income | ¥4,830M | ¥5,964M | ¥5,501M | ¥8,733M |
| Net Income | ¥3,247M | ¥4,267M | ¥4,607M | ¥7,275M |
| EPS | ¥54.16 | ¥67.69 | ¥69.95 | - |
| Operating Margin | 21.93% | 21.31% | 17.94% | 20.90% |
| Balance Sheet | ||||
| Total Assets | ¥62,053M | ¥98,567M | ¥122,452M | ¥143,020M |
| Total Equity | ¥31,170M | ¥64,539M | ¥70,590M | ¥78,022M |
| Total Liabilities | ¥30,883M | ¥34,028M | ¥51,862M | ¥64,998M |
| Cash | ¥13,192M | ¥22,782M | ¥14,473M | ¥32,176M |
| Interest-bearing Debt | ¥17,795M | ¥20,398M | ¥37,831M | ¥46,888M |
| Equity Ratio | 50.23% | 65.48% | 57.65% | 54.55% |
| D/E Ratio | 0.57 | 0.32 | 0.54 | 0.60 |
| Cash Flow | ||||
| Operating CF | ¥3,808M | ¥4,062M | -¥17M | ¥14,685M |
| Investing CF | -¥8,101M | -¥22,769M | -¥24,864M | -¥3,467M |
| Financing CF | -¥2,414M | ¥28,296M | ¥16,581M | ¥6,484M |
| Free CF | ¥2,486M | ¥2,122M | -¥2,275M | ¥10,992M |
| Efficiency | ||||
| ROE | 10.42% | 6.61% | 6.53% | 9.32% |
| ROA | 5.23% | 4.33% | 3.76% | 5.09% |
Latest IR Information
-
FY2026 Q3 Financial Results Presentation
Consolidated revenue amounted to JPY 36,488 million (YoY +23%), operating income was JPY 7,767 million (YoY +37%), and net income attributable to owners of parent was JPY 4,811 million (YoY +28%), showing steady growth.
Read more -
Q3 Financial Summary for Fiscal Year Ending March 2026 [IFRS] (Consolidated)
For Q3 of the fiscal year ending March 2026, revenue was JPY 36,488 million (YoY +23.2%), operating income was JPY 7,767 million (YoY +37.1%), and net income attributable to owners of parent was JPY 4,811 million (YoY +24.6%), achieving growth...
Read more
Latest News (5 items)
-
Average Analyst Rating: strong_buy
Average Target Price: ¥5,421
Rating Score: 1.25 (Based on 13 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
JMDC Inc. provides medical statistics data services in Japan. It operates through two segments: Health Big Data and Telemedicine. The company offers big data services for medical field, including WEB tool, analytic, raw data provision, and publication support services; data provision and aggregation, and solution development services; supporting health business for health insurance associations and local government health services; health data platform; and medical institution support services. It also provides JMDC Claims Database, an epidemiological receipt database that has accumulated receipts, including inpatient, outpatient, and dispensing, as well as medical examination data received from multiple health insurance associations. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, and research institutions. JMDC Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan. JMDC Inc. is a subsidiary of OMRON Corporation.